Lianpan Dai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Oxide Nanoparticles

Diffusion Weighted Imaging

Respiratory Syndrome Coronavirus

Top Venues

Signal transduction and targeted therapy

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 9 (1) (2024)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 9 (1) (2024)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 9 (1) (2024)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Yisheng Song, Jinjin Shao, Guangbiao She, Wan-Qiang Lv, Guoyu Chen, Jing Liu, Lili Zhang, Chengda Zhang, Jiahong Wang, Ruiyu Tian, Lianpan Dai, George Fu Gao, Enqi Huang, Lijiang Zhang
Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats. NPJ vaccines 8 (1) (2023)
Fengqiang Cao, Sha Peng, Yaling An, Kun Xu, Tianyi Zheng, Lianpan Dai, Kenji Ogino, To Ngai, Yufei Xia, Guanghui Ma
Inside-out assembly of viral antigens for the enhanced vaccination. Signal transduction and targeted therapy 8 (1) (2023)
Shuxin Guo, Yuxuan Zheng, Zhengrong Gao, Minrun Duan, Sheng Liu, Pan Du, XiaoYu Xu, Kun Xu, Xin Zhao, Yan Chai, Peiyi Wang, Qi Zhao, George Fu Gao, Lianpan Dai
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine. Cell discovery 9 (1) (2023)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George Fu Gao, Yuliang Zhao, Yaling Wang, Chunying Chen
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine. Signal transduction and targeted therapy 8 (1) (2023)
Pengfei Jin, Xiling Guo, Wei Chen, Shihua Ma, Hongxing Pan, Lianpan Dai, Pan Du, Lili Wang, Lai-Run Jin, Yin Chen, Fengjuan Shi, Jingxian Liu, Xiaoyu Xu, Yanan Zhang, George Fu Gao, Cancan Chen, Jialu Feng, Jingxin Li, Feng-Cai Zhu
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial. PLoS medicine 19 (5) (2022)
Yuxuan Han, Yaling An, Qian Chen, Kun Xu, Xueyuan Liu, Senyu Xu, Huixin Duan, Annette B Vogel, Uğur Şahin, Qihui Wang, Lianpan Dai, George Fu Gao
mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2. Cell research 32 (11) (2022)
Yaling An, Shihua Li, Xiyue Jin, Jian-Bao Han, Kun Xu, Senyu Xu, Yuxuan Han, Chuanyu Liu, Tianyi Zheng, Mei Liu, Mi Yang, Tian-Zhang Song, Baoying Huang, Li Zhao, Wen Wang, Ruhan A, Yingjie Cheng, Changwei Wu, Enqi Huang, Shilong Yang, Gary Wong, Yu-Hai Bi, Changwen Ke, Wenjie Tan, Jinghua Yan, Yong-Tang Zheng, Lianpan Dai, George Fu Gao
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates. Emerging microbes & infections 11 (1) (2022)
Kun Xu, Yaling An, Qunlong Li, Weijin Huang, Yuxuan Han, Tianyi Zheng, Fang Fang, Hui Liu, Chuanyu Liu, Ping Gao, Senyu Xu, Xueyuan Liu, Rong Zhang, Xin Zhao, William J Liu, Yu-Hai Bi, Youchun Wang, Dongming Zhou, Qinghan Wang, Wenli Hou, Qianfeng Xia, George Fu Gao, Lianpan Dai
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerging microbes & infections 10 (1) (2021)
Lianpan Dai, Kun Xu, Jinhe Li, Qingrui Huang, Jian Song, Yuxuan Han, Tianyi Zheng, Ping Gao, Xuancheng Lu, Huabing Yang, Kefang Liu, Qianfeng Xia, Qihui Wang, Yan Chai, Jianxun Qi, Jinghua Yan, George Fu Gao
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch. Nature immunology 22 (8) (2021)